Literature DB >> 16707445

Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling.

Qing Ren1, Csaba Kari, Marlene R D Quadros, Randy Burd, Peter McCue, Adam P Dicker, Ulrich Rodeck.   

Abstract

Previous studies addressing functional aspects of nuclear factor kappaB (NF-kappaB) activation in normal and transformed keratinocytes revealed complex and seemingly contradictory roles of this transcription factor in this cell type. In normal skin, NF-kappaB signaling seems to inhibit squamous cell carcinoma development whereas, in squamous cell carcinoma themselves, deregulated NF-kappaB expression and/or signaling is frequently observed. To further investigate this paradox, we focused on NF-kappaB activation as it relates to the transformed phenotype of immortalized but nontumorigenic human keratinocytes (HaCaT cells). We observed that NF-kappaB activity contributed to survival and growth of cultured HaCaT keratinocytes as shown by use of pharmacologic NF-kappaB inhibitors, RNA interference, and inducible overexpression of a dominant interfering IkappaB construct. NF-kappaB activation was largely provided through interaction with extracellular matrix components because preventing cell attachment by forced suspension culture markedly reduced NFkappaB signaling associated with cell death (anoikis); conversely, anoikis was partially reversed by NF-kappaB activation induced either by tumor necrosis factor-alpha treatment or by overexpressing the NF-kappaB p65 subunit in HaCaT cells. Furthermore, overexpression of NF-kappaBp65 in HaCaT cells induced colony formation in soft agar and tumorigenicity in nude mice. In summary, as opposed to normal keratinocytes, immortalized HaCaT keratinocytes provide a cellular context in which deregulated NF-kappaB signaling supports multiple malignant traits in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707445     DOI: 10.1158/0008-5472.CAN-05-4158

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.

Authors:  Zorica Janjetovic; Robert C Tuckey; Minh N Nguyen; Edwin M Thorpe; Andrzej T Slominski
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

2.  Microenvironment induced spheroid to sheeting transition of immortalized human keratinocytes (HaCaT) cultured in microbubbles formed in polydimethylsiloxane.

Authors:  Siddarth Chandrasekaran; Ut-Binh T Giang; Michael R King; Lisa A DeLouise
Journal:  Biomaterials       Date:  2011-07-02       Impact factor: 12.479

Review 3.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

4.  Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis.

Authors:  Moon-Il Kang; Alyson R Baker; Christopher R Dextras; Stephanie M Cabarcas; Matthew R Young; Nancy H Colburn
Journal:  Genes Cancer       Date:  2012-01

5.  20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Zorica Janjetovic; Robert C Tuckey; Radoslaw Bieniek; Junming Yue; Wei Li; Jianjun Chen; Minh N Nguyen; Edith K Y Tang; Duane Miller; Tai C Chen; Michael Holick
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-15       Impact factor: 4.249

6.  Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.

Authors:  Zhiyuan Ma; David J Vocadlo; Keith Vosseller
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

7.  Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos.

Authors:  Borbala Daroczi; Gabor Kari; Qing Ren; Adam P Dicker; Ulrich Rodeck
Journal:  Mol Cancer Ther       Date:  2009-09-01       Impact factor: 6.261

8.  Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma.

Authors:  Elana J Fertig; Qing Ren; Haixia Cheng; Hiromitsu Hatakeyama; Adam P Dicker; Ulrich Rodeck; Michael Considine; Michael F Ochs; Christine H Chung
Journal:  BMC Genomics       Date:  2012-05-01       Impact factor: 3.969

9.  Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.

Authors:  Stephen A Watt; Karin J Purdie; Nicoline Y den Breems; Michelle Dimon; Sarah T Arron; Angela T McHugh; Dylan J Xue; Jasbani H S Dayal; Charlotte M Proby; Catherine A Harwood; Irene M Leigh; Andrew P South
Journal:  Am J Pathol       Date:  2015-07-26       Impact factor: 4.307

10.  20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes.

Authors:  Zorica Janjetovic; Michal A Zmijewski; Robert C Tuckey; Damon A DeLeon; Minh N Nguyen; Lawrence M Pfeffer; Andrzej T Slominski
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.